Patent details
EP3508200 Title: AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE
Basic Information
- Publication number:
- EP3508200
- PCT Application Number:
- JP2017030107
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP178462453
- PCT Publication Number:
- WO2018043240
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE
- French Title of Invention:
- FORMULATION AQUEUSE CONTENANT DE L'ACIDE 5-AMINOLÉVULINIQUE OU SIMILAIRE
- German Title of Invention:
- WÄSSRIGE FORMULIERUNG MIT 5-AMINOLEVULINSÄURE ODER DERGLEICHEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 06/05/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 16/05/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 10/04/2024
- Unitary Effect Registration Date:
- 16/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 23/08/2017
- Grant date:
- 10/04/2024
- EP Publication Date:
- 10/07/2019
- PCT Publication Date:
- 08/03/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/04/2024
- EP B1 Publication Date:
- 10/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 23/08/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/04/2024
- Name:
- SBI Pharmaceuticals Co., Ltd.
- Address:
- 6-1, Roppongi 1-chome Minato-ku, Tokyo 106-6020, Japan (JP)
Inventor
1
- Name:
- MORISHITA, Mika
- Address:
- Japan (JP)
2
- Name:
- OTA, Urara
- Address:
- Japan (JP)
3
- Name:
- ISHIZUKA, Masahiro
- Address:
- Japan (JP)
Priority
- Priority Number:
- 2016171753
- Priority Date:
- 02/09/2016
- Priority Country:
- Japan (JP)
Classification
- IPC classification:
- A61K 31/197; A61K 31/22; A61K 31/221; A61K 31/222; A61K 31/295; A61K 9/06; A61K 9/08; A61K 47/02; A61K 47/12;
Publication
European Patent Bulletin
1
- Issue number:
- 202415
- Publication date:
- 10/04/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202424
- Publication date:
- 12/06/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|